Condition
Revision Total Hip Arthroplasty
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06626490RecruitingPrimary
Prospective Follow-up of the Prevision Hip Stem With Comparison of Different Implant Variants
NCT05657054Not ApplicableActive Not RecruitingPrimary
Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement
NCT04209426CompletedPrimary
Retrospective Observational Cohort Study of SYMBOL CUP DM 2
NCT02877381Phase 4Completed
Tranexamic Acid in Revision Total Joint Arthroplasty
NCT01482533UnknownPrimary
Tissue Culture Versus Swab Culture in Prosthetic Joint Infections
Showing all 5 trials